Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Ruxolitinib

Acute reversible kidney injury, pulmonary oedema and shortness of breath: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kirkham Z, et al. A single centre experience of ruxolitinib for treatment of steroid refractory chronic graft versus host disease. Bone Marrow Transplantation 57 (Suppl. 1): 215 (plus poster) abstr. P211, et al. Nov 2022. Available from: URL: http://doi.org/10.1038/s41409-022-01798-0 [abstract] Kirkham Z, et al. A single centre experience of ruxolitinib for treatment of steroid refractory chronic graft versus host disease. Bone Marrow Transplantation 57 (Suppl. 1): 215 (plus poster) abstr. P211, et al. Nov 2022. Available from: URL: http://​doi.​org/​10.​1038/​s41409-022-01798-0 [abstract]
Metadaten
Titel
Ruxolitinib
Acute reversible kidney injury, pulmonary oedema and shortness of breath: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-31287-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Insulin

Case report

Bicarbonate

Case report

Multiple drugs